1753-29-3 Usage
Uses
Used in Pharmaceutical Synthesis:
1,2,3-Benzothiadiazol-5-amine is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Production:
1,2,3-Benzothiadiazol-5-amine is also utilized in the production of agrochemicals, where it can contribute to the creation of novel pesticides or other agricultural products that enhance crop protection and yield.
Used in Dye Manufacturing:
1,2,3-Benzothiadiazol-5-amine is employed in the manufacturing of dyes due to its ability to impart color, which is valuable in various industries such as textiles, printing, and painting.
Used in Organic Electronic Devices:
1,2,3-Benzothiadiazol-5-amine is used as an electron-donating material in the development of organic electronic devices. Its application extends to organic light-emitting diodes (OLEDs) and organic photovoltaic cells (OPVs), where it can enhance the performance and efficiency of these devices.
Used in Biomedical Research:
Due to its demonstrated biological activities, including anti-inflammatory and anti-tumor effects, 1,2,3-Benzothiadiazol-5-amine is a compound of interest for further research in the biomedical field. Its potential use in developing new therapeutic agents for various diseases is currently being explored.
Check Digit Verification of cas no
The CAS Registry Mumber 1753-29-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,7,5 and 3 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1753-29:
(6*1)+(5*7)+(4*5)+(3*3)+(2*2)+(1*9)=83
83 % 10 = 3
So 1753-29-3 is a valid CAS Registry Number.
1753-29-3Relevant academic research and scientific papers
AMINO-QUINOLINES AS KINASE INHIBITORS
-
, (2015/09/23)
Disclosed are quinoline compounds having the formula: wherein R1, R2 and A are as defined herein, and methods of making and using the same.
7-AMINOFUROPYRIDINE DERIVATIVES
-
Page/Page column 49, (2011/09/15)
Compounds of Formula 1, as shown below and defined herein: pharmaceutically acceptable salts thereof, synthesis, intermediates, formulations, and methods of disease treatment therewith, including treatment of cancers, such as tumors driven at least in part by TAK1 or for which an appropriate TAK1 inhibitor is effective. This Abstract is not limiting of the invention.